Ryvu Therapeutics SA Cash Flow Quality Index
Ryvu Therapeutics SA cash flow quality index. Ryvu Therapeutics SA (RVU) has a Cash Flow Quality Index of -0.22x as of March 2018. Operating cash flow of zł-4.33 Million is below net income of zł19.89 Million, suggesting accrual-heavy earnings not yet converted to cash. See RVU financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Ryvu Therapeutics SA (2014–2018)
Cash flow quality index of Ryvu Therapeutics SA from 2014 to 2018. Historical Cash Flow Quality Index for Ryvu Therapeutics SA across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Ryvu Therapeutics SA service its debt to assess how comfortably operating cash covers total debt obligations.
Ryvu Therapeutics SA Cash Flow Quality Index by Year (2014–2018)
Ryvu Therapeutics SA cash flow quality index by year from 2014 to 2018. Year-by-year earnings quality comparison for Ryvu Therapeutics SA. For the full cash flow conversion analysis, see cash flow conversion of Ryvu Therapeutics SA.
| Year | Quality Index | Operating CF (PLN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | -40.80x | zł-36.42 Million | zł892.48K | ▼ -2601.3% |
| 2017 | 1.63x | zł10.98 Million | zł6.73 Million | ▲ +169.8% |
| 2016 | -2.34x | zł-6.28 Million | zł2.69 Million | ▲ +11.3% |
| 2015 | -2.64x | zł-16.43 Million | zł6.23 Million | ▼ -214.6% |
| 2014 | -0.84x | zł-4.90 Million | zł5.85 Million | — |